These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7687042)

  • 1. Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy.
    Laegreid L; Kyllerman M; Hedner T; Hagberg B; Viggedahl G
    Neuropediatrics; 1993 Apr; 24(2):88-92. PubMed ID: 7687042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital abnormalities in two sibs exposed to valproic acid in utero.
    Chitayat D; Farrell K; Anderson L; Hall JG
    Am J Med Genet; 1988 Oct; 31(2):369-73. PubMed ID: 3148279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
    Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
    J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study.
    Dravet C; Julian C; Legras C; Magaudda A; Guerrini R; Genton P; Soulayrol S; Giraud N; Mesdjian E; Trentin G
    Neurology; 1992 Apr; 42(4 Suppl 5):75-82. PubMed ID: 1574181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.
    Nau H; Rating D; Koch S; Häuser I; Helge H
    J Pharmacol Exp Ther; 1981 Dec; 219(3):768-77. PubMed ID: 6795343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.
    Kozma C
    Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development.
    Eriksson K; Viinikainen K; Mönkkönen A; Aikiä M; Nieminen P; Heinonen S; Kälviäinen R
    Epilepsy Res; 2005 Jul; 65(3):189-200. PubMed ID: 16029946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valproate treatment during pregnancy: description of four cases with foetal valproate syndrome].
    Sabers A; Larsen K; Blichfeldt S; Sahlholdt L; Rasmussen JO
    Ugeskr Laeger; 2009 Jan; 171(4):221-5. PubMed ID: 19174036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification of the fetal valproate syndrome phenotype.
    Ardinger HH; Atkin JF; Blackston RD; Elsas LJ; Clarren SK; Livingstone S; Flannery DB; Pellock JM; Harrod MJ; Lammer EJ
    Am J Med Genet; 1988 Jan; 29(1):171-85. PubMed ID: 3125743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy.
    Ornoy A
    Reprod Toxicol; 2006 Aug; 22(2):214-26. PubMed ID: 16621443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development.
    Titze K; Koch S; Helge H; Lehmkuhl U; Rauh H; Steinhausen HC
    Dev Med Child Neurol; 2008 Feb; 50(2):117-22. PubMed ID: 18177411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.
    Wikner BN; Stiller CO; Bergman U; Asker C; Källén B
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1203-10. PubMed ID: 17894421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.